Copyright
©The Author(s) 2019.
World J Gastroenterol. Dec 28, 2019; 25(48): 6902-6915
Published online Dec 28, 2019. doi: 10.3748/wjg.v25.i48.6902
Published online Dec 28, 2019. doi: 10.3748/wjg.v25.i48.6902
Term | Count | P value | Genes |
MicroRNAs in cancer | 7 | 0.002 | KIF23, CCNE1, MAP2K1, WNT3A, PIM1, HMGA2, CDC25A |
Pathways in cancer | 8 | 0.005 | CCNE1, RET, MAP2K1, WNT3A, ITGA2, LAMC1, AXIN2, PLCB1 |
p53 signaling pathway | 4 | 0.007 | STEAP3, CCNE1, SERPINE1, CHEK1 |
Chagas disease (American trypanosomiasis) | 4 | 0.024 | GNAL, IRAK1, SERPINE1, PLCB1 |
Proteoglycans in cancer | 5 | 0.024 | MAP2K1, WNT3A, ESR1, ITGA2, TWIST1 |
Cell cycle | 4 | 0.030 | CCNE1, CHEK1, WEE1, CDC25A |
PI3K-Akt signaling pathway | 6 | 0.038 | CCNE1, SGK1, MAP2K1, ITGA2, LAMC1, ANGPT2 |
Hippo signaling pathway | 4 | 0.048 | WNT3A, SERPINE1, AXIN2, SNAI2 |
Small cell lung cancer | 3 | 0.081 | CCNE1, ITGA2, LAMC1 |
Progesterone-mediated oocyte maturation | 3 | 0.082 | MAP2K1, CPEB3, CDC25A |
- Citation: Zeng YL, Guo ZY, Su HZ, Zhong FD, Jiang KQ, Yuan GD. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma. World J Gastroenterol 2019; 25(48): 6902-6915
- URL: https://www.wjgnet.com/1007-9327/full/v25/i48/6902.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i48.6902